Benefits of Empiric Nutritional and Medical Therapy for Semen Parameters and Pregnancy and Live Birth Rates in Couples with Idiopathic Infertility

A Systematic Review and Meta-analysis

Muhammad Imran Omar (Corresponding Author), Raj Prasenjit Pal, Brian D. Kelly, Harman Maxim Bruins, Yuhong Yuan, Thorsten Diemer, Csilla Krausz, Herman Tournaye, Zsolt Kopa, Andreas Jungwirth, Suks Minhas

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Context: The empiric use of medical and nutritional supplements to improve semen parameters and pregnancy rates in couples with idiopathic infertility has reached global proportions, although the evidence base for their use in this setting is controversial.
Objective: We systematically reviewed the evidence comparing the benefits of nutritional and medical therapy on pregnancy rate and semen parameters in men with idiopathic infertility.
Evidence acquisition: Literature search was performed using MEDLINE, EMBASE, LILACS and the Cochrane Library (searched from January 1st 1990 to September 19th 2017). We adopted the methods as detailed in the Cochrane Handbook. GRADE was adopted in order to assess certainty of evidence.
Evidence synthesis: Literature search identified 5663 citations, and after abstract and full-text screening 61 studies (59 RCTs and 2 non-randomised comparative studies) were included. Pooled results demonstrated that pentoxyfylline, co-enzyme Q10, L-carnitine, FSH, Tamoxifen and kallikrein all resulted in improvements in semen parameters. Individual studies identified several other medical and nutritional therapies that improved semen parameters, but data were limited to individual studies with inherent methodological flaws. There were limited data available on live birth and pregnancy rates for all interventions. GRADE certainty of evidence for all the outcomes was very low mainly due methodological flaws and inconsistencies with study design, and inconsistency. Some outcomes were also downgraded due to imprecision of results.
Conclusions: There is some evidence that empiric medical and nutritional supplements may improve semen parameters. There is very limited evidence that empiric therapy leads to improved live birth rates, spontaneous pregnancy or pregnancy following assisted-reproductive techniques. However, the findings should be interpreted with caution as there were some methodological flaws, as a number of studies were judged to be either at high or unclear risk of bias for many domains.
Patient summary: This review has identified several medical and nutritional treatments such as pentoxyfylline, co-enzyme Q10, L-carnitine, FSH, Tamoxifen and kallikrein, appear to improve semen parameters. In spite of this, there are limited data suggesting pregnancy and live birth rates are increased, and is attributable to methodological flaws in studies and the low number of reported pregnancies.
Original languageEnglish
Pages (from-to)615-625
Number of pages11
JournalEuropean Urology
Volume75
Issue number4
Early online date8 Jan 2019
DOIs
Publication statusPublished - Apr 2019

Fingerprint

Pregnancy Rate
Semen
Infertility
Meta-Analysis
coenzyme Q10
Kallikreins
Carnitine
Tamoxifen
Therapeutics
Pregnancy
Assisted Reproductive Techniques
MEDLINE
Libraries

Keywords

  • infertility
  • pregnancy
  • nutritional therapy
  • medical therapy
  • systematic review
  • meta-analysis
  • Pregnancy
  • Infertility
  • Medical therapy
  • Systematic review
  • Nutritional therapy
  • Meta-analysis

ASJC Scopus subject areas

  • Urology

Cite this

Benefits of Empiric Nutritional and Medical Therapy for Semen Parameters and Pregnancy and Live Birth Rates in Couples with Idiopathic Infertility : A Systematic Review and Meta-analysis. / Omar, Muhammad Imran (Corresponding Author); Pal, Raj Prasenjit; Kelly, Brian D.; Bruins, Harman Maxim; Yuan, Yuhong ; Diemer, Thorsten; Krausz, Csilla; Tournaye, Herman; Kopa, Zsolt; Jungwirth, Andreas; Minhas, Suks.

In: European Urology, Vol. 75, No. 4, 04.2019, p. 615-625.

Research output: Contribution to journalArticle

Omar, Muhammad Imran ; Pal, Raj Prasenjit ; Kelly, Brian D. ; Bruins, Harman Maxim ; Yuan, Yuhong ; Diemer, Thorsten ; Krausz, Csilla ; Tournaye, Herman ; Kopa, Zsolt ; Jungwirth, Andreas ; Minhas, Suks. / Benefits of Empiric Nutritional and Medical Therapy for Semen Parameters and Pregnancy and Live Birth Rates in Couples with Idiopathic Infertility : A Systematic Review and Meta-analysis. In: European Urology. 2019 ; Vol. 75, No. 4. pp. 615-625.
@article{35d095242d9946cda744fb53ef025ffa,
title = "Benefits of Empiric Nutritional and Medical Therapy for Semen Parameters and Pregnancy and Live Birth Rates in Couples with Idiopathic Infertility: A Systematic Review and Meta-analysis",
abstract = "Context: The empiric use of medical and nutritional supplements to improve semen parameters and pregnancy rates in couples with idiopathic infertility has reached global proportions, although the evidence base for their use in this setting is controversial.Objective: We systematically reviewed the evidence comparing the benefits of nutritional and medical therapy on pregnancy rate and semen parameters in men with idiopathic infertility.Evidence acquisition: Literature search was performed using MEDLINE, EMBASE, LILACS and the Cochrane Library (searched from January 1st 1990 to September 19th 2017). We adopted the methods as detailed in the Cochrane Handbook. GRADE was adopted in order to assess certainty of evidence.Evidence synthesis: Literature search identified 5663 citations, and after abstract and full-text screening 61 studies (59 RCTs and 2 non-randomised comparative studies) were included. Pooled results demonstrated that pentoxyfylline, co-enzyme Q10, L-carnitine, FSH, Tamoxifen and kallikrein all resulted in improvements in semen parameters. Individual studies identified several other medical and nutritional therapies that improved semen parameters, but data were limited to individual studies with inherent methodological flaws. There were limited data available on live birth and pregnancy rates for all interventions. GRADE certainty of evidence for all the outcomes was very low mainly due methodological flaws and inconsistencies with study design, and inconsistency. Some outcomes were also downgraded due to imprecision of results.Conclusions: There is some evidence that empiric medical and nutritional supplements may improve semen parameters. There is very limited evidence that empiric therapy leads to improved live birth rates, spontaneous pregnancy or pregnancy following assisted-reproductive techniques. However, the findings should be interpreted with caution as there were some methodological flaws, as a number of studies were judged to be either at high or unclear risk of bias for many domains. Patient summary: This review has identified several medical and nutritional treatments such as pentoxyfylline, co-enzyme Q10, L-carnitine, FSH, Tamoxifen and kallikrein, appear to improve semen parameters. In spite of this, there are limited data suggesting pregnancy and live birth rates are increased, and is attributable to methodological flaws in studies and the low number of reported pregnancies.",
keywords = "infertility, pregnancy, nutritional therapy, medical therapy, systematic review, meta-analysis, Pregnancy, Infertility, Medical therapy, Systematic review, Nutritional therapy, Meta-analysis",
author = "Omar, {Muhammad Imran} and Pal, {Raj Prasenjit} and Kelly, {Brian D.} and Bruins, {Harman Maxim} and Yuhong Yuan and Thorsten Diemer and Csilla Krausz and Herman Tournaye and Zsolt Kopa and Andreas Jungwirth and Suks Minhas",
note = "The authors would like to thank Julie Darraugh and Karin Plass from the EAU Guidelines Office for their assistance with the systematic review.",
year = "2019",
month = "4",
doi = "10.1016/j.eururo.2018.12.022",
language = "English",
volume = "75",
pages = "615--625",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Benefits of Empiric Nutritional and Medical Therapy for Semen Parameters and Pregnancy and Live Birth Rates in Couples with Idiopathic Infertility

T2 - A Systematic Review and Meta-analysis

AU - Omar, Muhammad Imran

AU - Pal, Raj Prasenjit

AU - Kelly, Brian D.

AU - Bruins, Harman Maxim

AU - Yuan, Yuhong

AU - Diemer, Thorsten

AU - Krausz, Csilla

AU - Tournaye, Herman

AU - Kopa, Zsolt

AU - Jungwirth, Andreas

AU - Minhas, Suks

N1 - The authors would like to thank Julie Darraugh and Karin Plass from the EAU Guidelines Office for their assistance with the systematic review.

PY - 2019/4

Y1 - 2019/4

N2 - Context: The empiric use of medical and nutritional supplements to improve semen parameters and pregnancy rates in couples with idiopathic infertility has reached global proportions, although the evidence base for their use in this setting is controversial.Objective: We systematically reviewed the evidence comparing the benefits of nutritional and medical therapy on pregnancy rate and semen parameters in men with idiopathic infertility.Evidence acquisition: Literature search was performed using MEDLINE, EMBASE, LILACS and the Cochrane Library (searched from January 1st 1990 to September 19th 2017). We adopted the methods as detailed in the Cochrane Handbook. GRADE was adopted in order to assess certainty of evidence.Evidence synthesis: Literature search identified 5663 citations, and after abstract and full-text screening 61 studies (59 RCTs and 2 non-randomised comparative studies) were included. Pooled results demonstrated that pentoxyfylline, co-enzyme Q10, L-carnitine, FSH, Tamoxifen and kallikrein all resulted in improvements in semen parameters. Individual studies identified several other medical and nutritional therapies that improved semen parameters, but data were limited to individual studies with inherent methodological flaws. There were limited data available on live birth and pregnancy rates for all interventions. GRADE certainty of evidence for all the outcomes was very low mainly due methodological flaws and inconsistencies with study design, and inconsistency. Some outcomes were also downgraded due to imprecision of results.Conclusions: There is some evidence that empiric medical and nutritional supplements may improve semen parameters. There is very limited evidence that empiric therapy leads to improved live birth rates, spontaneous pregnancy or pregnancy following assisted-reproductive techniques. However, the findings should be interpreted with caution as there were some methodological flaws, as a number of studies were judged to be either at high or unclear risk of bias for many domains. Patient summary: This review has identified several medical and nutritional treatments such as pentoxyfylline, co-enzyme Q10, L-carnitine, FSH, Tamoxifen and kallikrein, appear to improve semen parameters. In spite of this, there are limited data suggesting pregnancy and live birth rates are increased, and is attributable to methodological flaws in studies and the low number of reported pregnancies.

AB - Context: The empiric use of medical and nutritional supplements to improve semen parameters and pregnancy rates in couples with idiopathic infertility has reached global proportions, although the evidence base for their use in this setting is controversial.Objective: We systematically reviewed the evidence comparing the benefits of nutritional and medical therapy on pregnancy rate and semen parameters in men with idiopathic infertility.Evidence acquisition: Literature search was performed using MEDLINE, EMBASE, LILACS and the Cochrane Library (searched from January 1st 1990 to September 19th 2017). We adopted the methods as detailed in the Cochrane Handbook. GRADE was adopted in order to assess certainty of evidence.Evidence synthesis: Literature search identified 5663 citations, and after abstract and full-text screening 61 studies (59 RCTs and 2 non-randomised comparative studies) were included. Pooled results demonstrated that pentoxyfylline, co-enzyme Q10, L-carnitine, FSH, Tamoxifen and kallikrein all resulted in improvements in semen parameters. Individual studies identified several other medical and nutritional therapies that improved semen parameters, but data were limited to individual studies with inherent methodological flaws. There were limited data available on live birth and pregnancy rates for all interventions. GRADE certainty of evidence for all the outcomes was very low mainly due methodological flaws and inconsistencies with study design, and inconsistency. Some outcomes were also downgraded due to imprecision of results.Conclusions: There is some evidence that empiric medical and nutritional supplements may improve semen parameters. There is very limited evidence that empiric therapy leads to improved live birth rates, spontaneous pregnancy or pregnancy following assisted-reproductive techniques. However, the findings should be interpreted with caution as there were some methodological flaws, as a number of studies were judged to be either at high or unclear risk of bias for many domains. Patient summary: This review has identified several medical and nutritional treatments such as pentoxyfylline, co-enzyme Q10, L-carnitine, FSH, Tamoxifen and kallikrein, appear to improve semen parameters. In spite of this, there are limited data suggesting pregnancy and live birth rates are increased, and is attributable to methodological flaws in studies and the low number of reported pregnancies.

KW - infertility

KW - pregnancy

KW - nutritional therapy

KW - medical therapy

KW - systematic review

KW - meta-analysis

KW - Pregnancy

KW - Infertility

KW - Medical therapy

KW - Systematic review

KW - Nutritional therapy

KW - Meta-analysis

UR - http://www.scopus.com/inward/record.url?scp=85059543334&partnerID=8YFLogxK

UR - http://www.mendeley.com/research/benefits-empiric-nutritional-medical-therapy-semen-parameters-pregnancy-live-birth-rates-couples-idi

UR - https://abdn.pure.elsevier.com/en/en/researchoutput/benefits-of-empiric-nutritional-and-medical-therapy-for-semen-parameters-and-pregnancy-and-live-birth-rates-in-couples-with-idiopathic-infertility(35d09524-2d99-46cd-a744-fb53ef025ffa).html

U2 - 10.1016/j.eururo.2018.12.022

DO - 10.1016/j.eururo.2018.12.022

M3 - Article

VL - 75

SP - 615

EP - 625

JO - European Urology

JF - European Urology

SN - 0302-2838

IS - 4

ER -